nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP1A2—Carmustine—lymphatic system cancer	0.207	0.234	CbGbCtD
Flunitrazepam—CYP2E1—Mitoxantrone—lymphatic system cancer	0.168	0.19	CbGbCtD
Flunitrazepam—CYP2C19—Teniposide—lymphatic system cancer	0.151	0.17	CbGbCtD
Flunitrazepam—CYP2C9—Teniposide—lymphatic system cancer	0.125	0.142	CbGbCtD
Flunitrazepam—CYP3A4—Cytarabine—lymphatic system cancer	0.0739	0.0837	CbGbCtD
Flunitrazepam—CYP3A4—Teniposide—lymphatic system cancer	0.0728	0.0824	CbGbCtD
Flunitrazepam—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0509	0.0576	CbGbCtD
Flunitrazepam—CYP3A4—Vincristine—lymphatic system cancer	0.035	0.0397	CbGbCtD
Flunitrazepam—Sleep disorder—Fludarabine—lymphatic system cancer	0.0037	0.0318	CcSEcCtD
Flunitrazepam—Aggression—Bleomycin—lymphatic system cancer	0.00368	0.0316	CcSEcCtD
Flunitrazepam—Sweating—Teniposide—lymphatic system cancer	0.00269	0.0231	CcSEcCtD
Flunitrazepam—Disorientation—Bleomycin—lymphatic system cancer	0.00263	0.0225	CcSEcCtD
Flunitrazepam—Amnesia—Carmustine—lymphatic system cancer	0.00218	0.0187	CcSEcCtD
Flunitrazepam—Diplopia—Carmustine—lymphatic system cancer	0.00205	0.0176	CcSEcCtD
Flunitrazepam—Agitation—Teniposide—lymphatic system cancer	0.00202	0.0173	CcSEcCtD
Flunitrazepam—Ataxia—Carmustine—lymphatic system cancer	0.00193	0.0166	CcSEcCtD
Flunitrazepam—Ataxia—Vincristine—lymphatic system cancer	0.00184	0.0158	CcSEcCtD
Flunitrazepam—Muscular weakness—Carmustine—lymphatic system cancer	0.00181	0.0155	CcSEcCtD
Flunitrazepam—Confusional state—Teniposide—lymphatic system cancer	0.00181	0.0155	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00179	0.0154	CcSEcCtD
Flunitrazepam—Agitation—Fludarabine—lymphatic system cancer	0.00177	0.0152	CcSEcCtD
Flunitrazepam—Tachycardia—Teniposide—lymphatic system cancer	0.00175	0.015	CcSEcCtD
Flunitrazepam—Malaise—Fludarabine—lymphatic system cancer	0.00174	0.0149	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00173	0.0149	CcSEcCtD
Flunitrazepam—Muscular weakness—Vincristine—lymphatic system cancer	0.00173	0.0148	CcSEcCtD
Flunitrazepam—Hypotension—Teniposide—lymphatic system cancer	0.00167	0.0144	CcSEcCtD
Flunitrazepam—Discomfort—Fludarabine—lymphatic system cancer	0.00162	0.0139	CcSEcCtD
Flunitrazepam—Confusional state—Fludarabine—lymphatic system cancer	0.00159	0.0136	CcSEcCtD
Flunitrazepam—Rash—Mechlorethamine—lymphatic system cancer	0.00153	0.0132	CcSEcCtD
Flunitrazepam—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00153	0.0131	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00152	0.0131	CcSEcCtD
Flunitrazepam—Feeling abnormal—Teniposide—lymphatic system cancer	0.00148	0.0127	CcSEcCtD
Flunitrazepam—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00147	0.0126	CcSEcCtD
Flunitrazepam—Sweating—Vincristine—lymphatic system cancer	0.00145	0.0124	CcSEcCtD
Flunitrazepam—Hallucination—Carmustine—lymphatic system cancer	0.00141	0.0121	CcSEcCtD
Flunitrazepam—Sweating—Mitoxantrone—lymphatic system cancer	0.00141	0.0121	CcSEcCtD
Flunitrazepam—Dysarthria—Methotrexate—lymphatic system cancer	0.00138	0.0119	CcSEcCtD
Flunitrazepam—Fatigue—Fludarabine—lymphatic system cancer	0.00136	0.0117	CcSEcCtD
Flunitrazepam—Hallucination—Vincristine—lymphatic system cancer	0.00135	0.0116	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00131	0.0113	CcSEcCtD
Flunitrazepam—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0013	0.0111	CcSEcCtD
Flunitrazepam—Asthenia—Teniposide—lymphatic system cancer	0.00129	0.011	CcSEcCtD
Flunitrazepam—Malaise—Bleomycin—lymphatic system cancer	0.00128	0.011	CcSEcCtD
Flunitrazepam—Discomfort—Bleomycin—lymphatic system cancer	0.00119	0.0102	CcSEcCtD
Flunitrazepam—Confusional state—Bleomycin—lymphatic system cancer	0.00116	0.00999	CcSEcCtD
Flunitrazepam—Tremor—Carmustine—lymphatic system cancer	0.00116	0.00993	CcSEcCtD
Flunitrazepam—Agitation—Carmustine—lymphatic system cancer	0.00113	0.00974	CcSEcCtD
Flunitrazepam—Asthenia—Fludarabine—lymphatic system cancer	0.00113	0.0097	CcSEcCtD
Flunitrazepam—Rash—Teniposide—lymphatic system cancer	0.00113	0.0097	CcSEcCtD
Flunitrazepam—Dermatitis—Teniposide—lymphatic system cancer	0.00113	0.00969	CcSEcCtD
Flunitrazepam—Headache—Teniposide—lymphatic system cancer	0.00112	0.00964	CcSEcCtD
Flunitrazepam—Agitation—Vincristine—lymphatic system cancer	0.00108	0.0093	CcSEcCtD
Flunitrazepam—Hypotension—Bleomycin—lymphatic system cancer	0.00108	0.00926	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00106	0.00914	CcSEcCtD
Flunitrazepam—Anxiety—Carmustine—lymphatic system cancer	0.00105	0.00899	CcSEcCtD
Flunitrazepam—Malaise—Mitoxantrone—lymphatic system cancer	0.00104	0.00889	CcSEcCtD
Flunitrazepam—Confusional state—Carmustine—lymphatic system cancer	0.00102	0.00872	CcSEcCtD
Flunitrazepam—Rash—Fludarabine—lymphatic system cancer	0.000993	0.00852	CcSEcCtD
Flunitrazepam—Dermatitis—Fludarabine—lymphatic system cancer	0.000992	0.00852	CcSEcCtD
Flunitrazepam—Headache—Fludarabine—lymphatic system cancer	0.000986	0.00847	CcSEcCtD
Flunitrazepam—Tachycardia—Carmustine—lymphatic system cancer	0.000983	0.00844	CcSEcCtD
Flunitrazepam—Anxiety—Mitoxantrone—lymphatic system cancer	0.000974	0.00836	CcSEcCtD
Flunitrazepam—Discomfort—Mitoxantrone—lymphatic system cancer	0.000965	0.00829	CcSEcCtD
Flunitrazepam—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000951	0.00817	CcSEcCtD
Flunitrazepam—Confusional state—Mitoxantrone—lymphatic system cancer	0.000945	0.00811	CcSEcCtD
Flunitrazepam—Hypotension—Carmustine—lymphatic system cancer	0.000942	0.00808	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00093	0.00798	CcSEcCtD
Flunitrazepam—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000914	0.00785	CcSEcCtD
Flunitrazepam—Irritability—Methotrexate—lymphatic system cancer	0.000906	0.00778	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000906	0.00778	CcSEcCtD
Flunitrazepam—Hypotension—Vincristine—lymphatic system cancer	0.000899	0.00772	CcSEcCtD
Flunitrazepam—Somnolence—Carmustine—lymphatic system cancer	0.000896	0.00769	CcSEcCtD
Flunitrazepam—Ataxia—Methotrexate—lymphatic system cancer	0.000893	0.00767	CcSEcCtD
Flunitrazepam—Hypotension—Mitoxantrone—lymphatic system cancer	0.000875	0.00752	CcSEcCtD
Flunitrazepam—Somnolence—Mitoxantrone—lymphatic system cancer	0.000833	0.00715	CcSEcCtD
Flunitrazepam—Feeling abnormal—Carmustine—lymphatic system cancer	0.00083	0.00713	CcSEcCtD
Flunitrazepam—Fatigue—Vincristine—lymphatic system cancer	0.000829	0.00712	CcSEcCtD
Flunitrazepam—Asthenia—Bleomycin—lymphatic system cancer	0.000828	0.00711	CcSEcCtD
Flunitrazepam—Fatigue—Mitoxantrone—lymphatic system cancer	0.000808	0.00693	CcSEcCtD
Flunitrazepam—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000772	0.00663	CcSEcCtD
Flunitrazepam—Drowsiness—Methotrexate—lymphatic system cancer	0.000732	0.00628	CcSEcCtD
Flunitrazepam—Rash—Bleomycin—lymphatic system cancer	0.000728	0.00625	CcSEcCtD
Flunitrazepam—Dermatitis—Bleomycin—lymphatic system cancer	0.000727	0.00624	CcSEcCtD
Flunitrazepam—Asthenia—Carmustine—lymphatic system cancer	0.000723	0.00621	CcSEcCtD
Flunitrazepam—Sweating—Methotrexate—lymphatic system cancer	0.000702	0.00602	CcSEcCtD
Flunitrazepam—Asthenia—Vincristine—lymphatic system cancer	0.00069	0.00593	CcSEcCtD
Flunitrazepam—Asthenia—Mitoxantrone—lymphatic system cancer	0.000672	0.00577	CcSEcCtD
Flunitrazepam—Dizziness—Carmustine—lymphatic system cancer	0.000666	0.00572	CcSEcCtD
Flunitrazepam—Dizziness—Vincristine—lymphatic system cancer	0.000636	0.00546	CcSEcCtD
Flunitrazepam—Rash—Carmustine—lymphatic system cancer	0.000635	0.00545	CcSEcCtD
Flunitrazepam—Dermatitis—Carmustine—lymphatic system cancer	0.000635	0.00545	CcSEcCtD
Flunitrazepam—Headache—Carmustine—lymphatic system cancer	0.000631	0.00542	CcSEcCtD
Flunitrazepam—Rash—Vincristine—lymphatic system cancer	0.000606	0.00521	CcSEcCtD
Flunitrazepam—Dermatitis—Vincristine—lymphatic system cancer	0.000606	0.0052	CcSEcCtD
Flunitrazepam—Headache—Vincristine—lymphatic system cancer	0.000603	0.00517	CcSEcCtD
Flunitrazepam—Rash—Mitoxantrone—lymphatic system cancer	0.000591	0.00507	CcSEcCtD
Flunitrazepam—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00059	0.00507	CcSEcCtD
Flunitrazepam—Headache—Mitoxantrone—lymphatic system cancer	0.000587	0.00504	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000531	0.00456	CcSEcCtD
Flunitrazepam—Malaise—Methotrexate—lymphatic system cancer	0.000516	0.00443	CcSEcCtD
Flunitrazepam—Discomfort—Methotrexate—lymphatic system cancer	0.000481	0.00413	CcSEcCtD
Flunitrazepam—Confusional state—Methotrexate—lymphatic system cancer	0.000471	0.00404	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000451	0.00387	CcSEcCtD
Flunitrazepam—Hypotension—Methotrexate—lymphatic system cancer	0.000436	0.00374	CcSEcCtD
Flunitrazepam—Somnolence—Methotrexate—lymphatic system cancer	0.000415	0.00356	CcSEcCtD
Flunitrazepam—Fatigue—Methotrexate—lymphatic system cancer	0.000402	0.00345	CcSEcCtD
Flunitrazepam—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000385	0.0033	CcSEcCtD
Flunitrazepam—Asthenia—Methotrexate—lymphatic system cancer	0.000335	0.00288	CcSEcCtD
Flunitrazepam—Dizziness—Methotrexate—lymphatic system cancer	0.000309	0.00265	CcSEcCtD
Flunitrazepam—Rash—Methotrexate—lymphatic system cancer	0.000294	0.00253	CcSEcCtD
Flunitrazepam—Dermatitis—Methotrexate—lymphatic system cancer	0.000294	0.00252	CcSEcCtD
Flunitrazepam—Headache—Methotrexate—lymphatic system cancer	0.000292	0.00251	CcSEcCtD
